David J. Leffell
Dr. Leffell is an internationally renowned dermatologist and a leader in skin health. He is the founder of the Dermatologic Surgery Program at Yale Medicine, a program recognized for its excellence in patient care, research, and education. He has authored more than 200 publications and has been an editor of the world’s leading textbook of dermatology, Fitzpatrick’s Dermatology in General Medicine. Dr. Leffell's dedication to patient care, research, and education makes him a valuable asset to BiologicsMD’s Board of Directors.
David Scheer
Mr. David Scheer is the founder and President of Scheer & Company, which provides strategic and transactional advisory services to companies in the life sciences industry. Mr. Scheer brings decades of experience to BiologicsMD, having founded, built and advised multiple biotechnology companies, including Achillion, Esperion Therapeutics, OraPharma, and Viropharma, which were acquired for nearly $7 Billion cumulatively. In addition to his advisory roles, Mr. Scheer serves as a member of the Board of Directors of BioCT and as a member of the Bioscience Innovation Advisory Committee, which oversees investments made by the $200M Connecticut Bioscience Innovation Fund. Mr. Scheer holds an A.B. degree cum laude in Biochemical Sciences from Harvard College and an M.S. degree in Cell, Molecular and Developmental Biology from Yale University.